Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
about
Local ablative treatments for hepatocellular carcinoma: An updated reviewAngiogenesis and liver fibrosisConophylline inhibits non-alcoholic steatohepatitis in miceInfluence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.Nonalcoholic fatty liver disease and aging: epidemiology to management.HIF3A DNA Methylation Is Associated with Childhood Obesity and ALT.Endogenous hydrogen sulfide is associated with angiotensin II type 1 receptor in a rat model of carbon tetrachloride-induced hepatic fibrosisGlucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese miceDiagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients.Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targetsRisk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis.
P2860
Q28078113-200BA61D-B227-4C96-8E85-CA5A7B4F106EQ28082569-D601C2E2-0D32-47C8-97BC-236DFE960627Q33778383-7DCAA34E-0EBA-41A5-AF2A-5E580B4AED38Q33853786-CFED67BF-4879-4F1B-A846-B987AF6FE404Q34366861-F7B218CF-2B99-4A90-9106-EB65DA1430D3Q35881871-A1DF311D-A5DF-4416-81B7-C1A04FE17902Q35919778-C4CD3BBA-5B3D-4E4C-B286-D2356486387AQ36621486-BCB1B5B3-3AEF-46AC-B169-8A6CCB93C3F0Q38261236-10D13FBF-661A-4099-9C48-C480BCA48BDBQ40939536-74F1C285-E413-461D-903A-C0B895930294Q41694135-FF5DB069-409A-4A6C-8065-D653DBB8DBB5Q41921861-4212C37E-891B-495A-BFD1-8DA8751584F7Q47106953-474D2D3B-42DB-4939-828C-AD0D2176F3E6Q51157373-3B919A37-4937-44CE-979A-3D1B7F9D1272Q52598231-0380D6BC-3BFA-4F5A-81DB-806AD3421938Q54978608-5747BBC0-22DE-4434-8280-DCC1E8CED96C
P2860
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@en
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@nl
type
label
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@en
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@nl
prefLabel
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@en
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@nl
P2093
P2860
P1476
Angiotensin II type 1 receptor ...... nonalcoholic steatohepatitis.
@en
P2093
Haruhisa Nakao
Hiroyuki Kanamori
Kazunobu Aso
Masakazu Haneda
Masashi Yoneda
Mitsuyoshi Okada
Shiro Yokohama
Taeko Yamauchi
Tomohiko Ohashi
P2860
P304
P356
10.1007/S00535-012-0651-7
P577
2012-08-14T00:00:00Z